# Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates
Canonical URL: https://biopharmsignal.com/news/ACHV/achieve-life-sciences-reports-first-quarter-2026-financial-results-and-provides-business-updates
Ticker: ACHV
Company: Achieve Life Sciences
Source: Achieve Life Sciences
Published: 2026-05-12 11:00 EST
Original Source URL: https://ir.achievelifesciences.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-06-29 12:30 EST — [Achieve Life Sciences Joins Russell 2000® Index](https://biopharmsignal.com/news/ACHV/achieve-life-sciences-joins-russell-2000-index-26eba5ff) — Source: Achieve Life Sciences
- 2026-06-22 12:30 EST — [Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA](https://biopharmsignal.com/news/ACHV/achieve-life-sciences-receives-complete-response-letter-from-fda-for-cytisinicli-673c44de) — Source: Achieve Life Sciences
- 2026-06-02 12:30 EST — [Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors](https://biopharmsignal.com/news/ACHV/achieve-life-sciences-appoints-jeffrey-farrow-and-reid-waldman-md-to-board-of-directors) — Source: Achieve Life Sciences
- 2026-05-19 18:15 EST — [Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment](https://biopharmsignal.com/news/ACHV/achieve-life-sciences-presents-safety-data-from-52-weeks-of-continuous-cytisinicline-treatment) — Source: Achieve Life Sciences
- 2026-05-12 11:05 EST — [Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma](https://biopharmsignal.com/news/ACHV/achieve-life-sciences-strengthens-board-and-commercial-leadership-with-three-senior-appointments-from-team-previously-at-verona-pharma) — Source: Achieve Life Sciences
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)